Share search
Client login
Menu
Careers
Intermediaries
Media Centre
Investment Management
Stockbroking
IPOs
ISAs
Location Finder
Search for your local office
Submit
Share Search
Share Prices & Company Research
Investment Management
Our Services
Managed Portfolios
Retirement Planning
IHT Planning
Transfer your portfolio
Contact Us
Our Approach
Our Investment Process
Our Investment Approach
Our Fees
Are you looking for peace of mind in retirement?
You could look to mitigate inheritance tax (IHT) by investing in a portfolio of qualifying shares traded on the Alternative Investment Market (AIM).
Find out more
Stockbroking
Our Services
Open an account and start trading
Transfer to us from another provider
Talk to a stockbroker
Receive advice on stocks and shares
Investing for children
Invest for my pension
Publications and Newsletters
Share prices & company research
Take control over your investment decisions.
View our range of stock market publications and newsletters.
View our Publications
New Issues
ISAs
Pensions
Latest News
About Us
Login
Home
Investment Management
Stockbroking
Open an account and start trading
Transfer to us from another provider
Talk to a stockbroker
Receive advice on stocks and shares
Investing for children
Invest for my pension
Publications and Newsletters
New Issues
ISAs
Pensions
Latest News
About Us
Share Prices & Company Research
Home
Stockbroking
NMC Health
Stockbroking
NMC Health
Current Price 2518.00p
Bid 2514.00p
Ask 2518.00p
Change -0.47%
Last Updated: 13/12/2019 12:36. Prices delayed by at least 15 minutes.
Call 0113 243 6941
or search for your local office
Summary
Charts
News
Financials
Company Overview
NMC Healthcare LLC is the leading private healthcare operator in the GCC with an international network of hospitals across 19 countries. NMC also ranks as one of the top 3 in-vitro fertilisation (IVF) operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing an aggressive international expansion program from 2016, the company now has over 34% of its licensed bed capacity in the Kingdom of Saudi Arabia (KSA), where the company has introduced long-term and multi-specialty care services. Moreover, the recent formation of a joint venture with GOSI/Hassana Investment Company is set to substantially boost the Group's bed capacity in KSA, with the JV expected to be the second largest healthcare operator in the Kingdom in terms of number of beds. NMC received over 7.5m patients in 2018. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$2.1 billion for the year ended 31 December 2018.
Financial Highlights Year Ended 31/12/2018
Turnover
£2,057.25m
Operating Profit
£379.82m
Dividend Yield
0.72
Dividend Per Share
18.10
Dividend Cover
6.61
P/E Ratio
21.05
More Financials
Key Personnel
Dr Bavaguthu Raghuram Shetty
Chief Executive Officer
Prasanth Manghat
Dep Chief Executive
Hani Buttikhi
Non-Executive Director
Dr Ayesha Mohammed Abdullah
Non-Executive Director
Khaleefa Butti Omair Yousif Almuhairi
Non-Executive Director
Patrick James Meade
Non-Executive Director
Salma Ali Said Bin Hareb
Non-Executive Director
Jonathan Galton Bomford
Non-Executive Director
Abdulrahman Sadiq Salim Basaddiq
Non-Executive Director
Tarek Alnabulsi
Non-Executive Director
Henry John Mark Tompkins
Non-Executive jt Chairman
Stock Details
EPIC
NMC
ISIN
GB00B7FC0762
Shares in Issue
208,903,861
Market cap
£5,258.11m
Sector
Health Care Providers
Analyst Views (2)
Strong Buy
100.00%
Buy
0.00%
Hold
0.00%
Sell
0.00%
Strong Sell
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.
Price Summary
Mid Price
2516.00p
Bid Price
2514.00p
Ask Price
2518.00p
Volume
134612
Change Today
-12.00p
% Change Today
-0.47%
Open
2544.00p
Previous Close
2528.00p
Intraday High
2584.00p
Intraday Low
2492.00p
52 Week High
3256.00p
52 Week Low
1773.50p
52 week high and low figures quoted above are calculated from intraday price data.
Intra-Day Chart
More Charts
NMC Health News
News in this section is provided by AJ Bell
UK stocks hold onto gains on trade deal optimism
25 Nov 2019 | 17:03
UK market lifted by trade hopes, M&S gains on new board hire
25 Nov 2019 | 11:58
Broker Forecast - Goldman Sachs issues a broker note on NMC Health PLC
28 Oct 2019 | 09:50
NMC Health reiterates annual guidance after stronger second half
21 Oct 2019 | 14:29
Director Deals - NMC Health PLC (NMC)
27 Sep 2019 | 14:20
FTSE 100 firms as Brexit bickering ups pressure on pound, Persimmon leads risers
27 Sep 2019 | 12:23
FTSE ends the week with a small gain, small-caps in pain
30 Aug 2019 | 16:37
UK stocks consolidate gains heading into weekend
30 Aug 2019 | 12:08
UK market accelerates decline as US open fails to lift Fed rate rise doubts
22 Aug 2019 | 17:05
Fed rate worries continue to drag on UK markets, buyout talk rallies NMC Health
22 Aug 2019 | 12:14
NMC Health posts increase in H1 earnings, confirms FY guidance
22 Aug 2019 | 08:21
UK stocks swing back into profit on US trade move
13 Aug 2019 | 17:08
UK stocks slip further in midday trade
13 Aug 2019 | 12:09
UK stocks slip further in midday trade
13 Aug 2019 | 12:02
Broker Forecast - Barclays Capital issues a broker note on NMC Health PLC
09 Aug 2019 | 10:10
Broker Forecast - Jefferies International issues a broker note on NMC Health PLC
09 Jul 2019 | 10:30
Broker Forecast - Barclays Capital issues a broker note on NMC Health PLC
04 Jul 2019 | 10:40
Director Deals - NMC Health PLC (NMC)
30 May 2019 | 14:00
Steady US open fails to save FTSE from fall
28 May 2019 | 16:38
UK stocks open 0.4% higher, led by miners
28 May 2019 | 09:04
NMC Healthcare completes Saudi Arabia JV; upgrades guidance
28 May 2019 | 07:34
Broker Forecast - Jefferies International issues a broker note on NMC Health PLC
22 May 2019 | 10:10
Director Deals - NMC Health PLC (NMC)
17 May 2019 | 15:00
Upbeat US jobs data sparks rise in global equities
05 Apr 2019 | 16:59
Progress with US-China trade talks fails to fuel FTSE
05 Apr 2019 | 12:04
FTSE rises as sterling weakens ahead of another Brexit vote
28 Mar 2019 | 17:04
Broker Forecast - Goldman Sachs issues a broker note on NMC Health PLC
25 Mar 2019 | 12:30
European growth shock hits stocks
07 Mar 2019 | 16:40
FTSE hit by global growth fears, ex-dividends
07 Mar 2019 | 12:07
Finance costs jump at NMC Health
07 Mar 2019 | 11:25
Assets (£m)
Data has been provided by AJ Bell
Reporting Date
31 Dec 2018
31 Dec 2017
31 Dec 2016
31 Dec 2015
31 Dec 2014
Tangible Assets
829.9
607.1
459.3
433.5
368.4
Intangible Assets & Goodwill
1,618.5
1,156.9
653.0
413.1
4.2
Investments & Other Non-Current Assets
32.6
46.5
56.8
3.0
0.0
Total Non-Current Assets
2,480.9
1,810.5
1,169.1
849.6
372.6
Inventory
247.3
181.3
144.4
134.8
110.2
Trade & Receivables
639.1
518.8
374.5
282.5
196.6
Cash & Receivables
324.0
202.0
479.9
118.5
79.6
Other Current Assets & Assets Held for Resale
181.0
226.3
149.1
68.5
191.6
Total Assets
3,872.4
2,939.0
2,317.0
1,453.9
950.5
Liabilities (£m)
Data has been provided by AJ Bell
Reporting Date
31 Dec 2018
31 Dec 2017
31 Dec 2016
31 Dec 2015
31 Dec 2014
Short Term Liabilities
960.1
703.8
660.2
402.3
370.6
Long Term Liabilities
1,555.6
1,090.6
708.0
551.9
126.9
Other Liabilities / Pension etc
0.0
0.0
0.0
0.0
0.0
Total Liabilities
2,515.7
1,794.4
1,368.1
954.2
497.5
Net Assets (£m)
Data has been provided by AJ Bell
Reporting Date
31 Dec 2018
31 Dec 2017
31 Dec 2016
31 Dec 2015
31 Dec 2014
Net Assets
1,356.8
1,144.6
948.9
499.7
453.0
Equity (£m)
Data has been provided by AJ Bell
Reporting Date
31 Dec 2018
31 Dec 2017
31 Dec 2016
31 Dec 2015
31 Dec 2014
Share Capital
32.4
31.9
31.9
29.6
29.6
Minority Interests
53.0
54.9
42.0
12.0
4.0
Retained Earnings
626.0
603.2
436.3
318.1
250.3
Share Premium Account
633.7
492.6
491.8
179.2
179.2
Other Equity
11.6
-38.1
-53.2
-39.1
-10.0
Total Equity
1,356.8
1,144.6
948.9
499.7
453.0
Cashflow (£m)
Data has been provided by AJ Bell
Reporting Date
31 Dec 2018
31 Dec 2017
31 Dec 2016
31 Dec 2015
31 Dec 2014
Cashflow from Operating Activities
387.8
277.5
176.4
84.1
85.7
Cashflow Before Financing
-290.8
-443.7
-194.0
-340.4
58.6
Increase / Decrease in Cash
101.6
-226.9
349.4
-52.3
57.1
Income (£m)
Data has been provided by AJ Bell
Reporting Date
31 Dec 2018
31 Dec 2017
31 Dec 2016
31 Dec 2015
31 Dec 2014
Turnover
2,057.3
1,603.4
1,220.8
880.9
643.9
Cost of Sales
1,216.1
968.0
753.3
575.9
434.7
Gross Profit
841.1
635.4
467.5
304.9
209.2
Operating Profit
379.8
273.5
184.1
110.9
88.4
Pre-Tax Profit
256.9
210.4
151.6
85.4
77.5
Profit / Loss for the Year
251.9
209.2
151.4
85.8
77.5
Dividend History
Data has been provided by AJ Bell
Period
Ex-Dividend Date
Payment Date
Net Dividend
Currency
Total for Year
H2 Dividend
13 Jun 2019
10 Jul 2019
18.10
GBX
18.10
H2 Dividend
14 Jun 2018
10 Jul 2018
13.00
GBX
13.00
H2 Dividend
11 May 2017
02 Jun 2017
10.60
GBX
10.60
H2 Dividend
19 May 2016
20 Jun 2016
6.20
GBX
6.20
H2 Dividend
28 May 2015
25 Jun 2015
5.40
GBX
5.40
Important
Terms of Use
Privacy Policy
Terms & Conditions
Order Execution
Conflicts of Interest
Complex Instruments
HELP
Brochures and Forms
Make a Payment
Frequently Asked Questions
Glossary
Contact Us
Site Map
INFORMATION
Our Service Levels
Treating Customers Fairly
Protection of Client Assets
Engagement Policy
Investment Risk
Pillar 3 Disclosures
Investors In People (IIP)
Follow Us
Website © Redmayne Bentley 2019
Redmayne Bentley LLP is a Limited Liability Partnership. Registered in England and Wales. Registered No: OC344361
Registered Office: 9 Bond Court, Leeds LS1 2JZ. VAT No: GB 165 8810 81. LEI: 213800S3IRIPK1R3JQ58
Members of the London Stock Exchange. Authorised and Regulated by the Financial Conduct Authority.
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our
Cookie Policy
. Your continued use of this site means you consent to the use of cookies.
Hide